Per Stål

14.6k citations
136 papers · 7.8k · 4 hit papers · h-index 36

Impact in

  • Hepatology top 0.2%
    • Liver Disease and Transplantation
    • Liver Diseases and Immunity
    • Hepatocellular Carcinoma Treatment and Prognosis
    • Hepatitis C virus research
  • Epidemiology top 0.1%
    • Liver Disease Diagnosis and Treatment

Papers in

    • Liver Disease Diagnosis and Treatment 42
    • Hepatocellular Carcinoma Treatment and Prognosis 21
    • Liver physiology and pathology 8
    • Liver Disease and Transplantation 8
    • Liver Diseases and Immunity 7
    • Hepatitis C virus research 6

Per Stål

132 papers receiving 7.7k citations

Per Stål's Hit Papers

Fibrosis stage but not NASH predicts mortality and time to development of severe liver disease in biopsy-proven NAFLD 2017 · 757 citations
7570+5+11Years since publication50010001.5k

Peers

Per Stål
Comparison fields: 5 of 122
  • Hepatology 2.1k
  • Epidemiology 5.4k
  • Endocrinology, Diabetes and Metabolism 1.4k
  • Pathology and Forensic Medicine 691
  • Hematology 398
Replace Paola Dongiovanni with:
Paola Dongiovanni Italy
Christopher L. Bowlus United States
Anna Ludovica Fracanzani Italy
Christian Datz Austria
Marco Lenzi Italy
David Cassiman Belgium
Sumio Kawata Japan
Silvia Fargion Italy
Julie R. Jonsson Australia
Ran Oren Israel
Per Stål relative to Paola Dongiovanni Italy Paola Dongiovanni's profile →
Citations per field
00.5×1.5×
Paola Dongiovanni · 1×
Citations per year

Countries citing papers authored by Per Stål

Since Specialization
Citations

This map shows the geographic impact of Per Stål's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Per Stål with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Per Stål more than expected).

Fields of papers citing papers by Per Stål

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Per Stål. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Per Stål. The network helps show where Per Stål may publish in the future.

Co-authors

The 25 scholars most cited alongside Per Stål, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Per Stål Line = papers co-authored together Per Stål links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 136 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Fibrosis stage is the strongest predictor for disease‐specific mortality in NAFLD after up to 33 years of follow‐up
Hit paper breakdown →
20141695
2
Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta‐analysis
Hit paper breakdown →
20171385
3
Fibrosis stage but not NASH predicts mortality and time to development of severe liver disease in biopsy-proven NAFLD
Hit paper breakdown →
2017757
4
Decreased Survival of Subjects With Elevated Liver Function Tests During A 28-Year Follow-Up
Hit paper breakdown →
2009606
5 2017224
6 2003199
7 2013176
8 2021151
9 2015123
10 201887
11 199881
12 201680
13 201879
14 201070
15 201969
16 201665
17 199361
18 201655
19 201955
20 201454

About Per Stål

Per Stål is a scholar working on Epidemiology, Hepatology, Hematology, Molecular Biology and Pathology and Forensic Medicine, having authored 136 papers that have together received 7.8k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (42 papers), Hepatocellular Carcinoma Treatment and Prognosis (21 papers), Iron Metabolism and Disorders (21 papers), Liver physiology and pathology (8 papers), Liver Disease and Transplantation (8 papers), Liver Diseases and Immunity (7 papers), Hepatitis C virus research (6 papers) and Alcohol Consumption and Health Effects (6 papers). The work is most often cited by research in Hepatology (2.1k citations), Epidemiology (5.4k citations), Endocrinology, Diabetes and Metabolism (1.4k citations), Pathology and Forensic Medicine (691 citations) and Hematology (398 citations). Per Stål has collaborated with scholars based in Sweden, United States and France. Frequent co-authors include Rolf Hultcrantz, Hannes Hagström, Mattias Ekstedt, Stergios Kechagias, Patrik Nasr, Mats Fredrikson, Ulf Hammar, Johan Askling, Hans Glaumann and Greger Lindberg. Their work appears in journals such as Scandinavian Journal of Gastroenterology, Journal of Hepatology, Liver International, Hepatology and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact